## 



## 

|The Medway<br>Mission||to Mariners||
|---|---|---|---|
|Contents||||
||||Page|
|Report ofthe trustees||||
|Independent<br>examiners||report||
|Statement<br>of financial||activities||
|Balance sheet||||
|Notes to the financial|statements||8 —12|





## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 



## 







## 

## 

## 

## 

## 

## 

## 



## 

## 

|||Endowment|Unrestricted|2023|2022|
|---|---|---|---|---|---|
||Note|Funds|Funds|Total|Total|
|||F|6|F|F|
|Income and endowments||||||
|Investments|||28,020|28,020|26,362|
|Expenditure||||||
|Cost of grant making||||||
|- Royal Naval Benevolent|Trust for|||||
|Pembroke<br>House,<br>Gillingham|||(12,500)|(12,500)|(14,860)|
|- Hospital<br>of Sir John Hawkins|||(10,000)|(10,000)|(12,000)|
|- Mission to Seafarers|||2,500)|2,500|5,000|
||||(25,000)|(25,000)|(31,860)|
|Charitable<br>activities||||||
|-Trustees expenses|||(643)|(643)|(500)|
|-Annual<br>return fee|||(13)|(13)|0|
|- Independent<br>examiner's|fee||(1,687)|(1,687)|(1,479)|
|Cost of raising funds||||||
|- Investment<br>management|costs|6,913)||(6,913|7,245)|
|Total expenditure||6,913)|(27,343|(34,256|41,084)|
|Net income/(expenditure)|before|||||
|gains and losses on investments||(6,913)|677|(6,236)|(14,722)|
|Net gains and losses on|investments|(92,906||92,906)|47,437|
|Net movements<br>in funds||(99,819)|677|(99,142)|32,715|
|Total funds brought forward||894,416|10,176|904,592|871,877|
|Total funds carried forward||794,597|10,853|805,450|904,592|





|The Medway|Mission to Mariners|||||
|---|---|---|---|---|---|
|Balance sheet||||||
|For the year|ended 5 April 2023|||||
|||||2023|2022|
|||Note||Total|Total|
|Fixed assets||||||
|Investments|||3|764,078|860,423|
|Current assets||||||
|Cash at bank|||4|44,717|47,519|
|Current liabilities||||||
|Creditors|||5~(3,345||(3,350)|
|Net current assets||||41,372|44,169|
|Total assets||||805,450|904,592|
|Represented|by|||||
|Endowment|funds|||||
|Capital<br>fund|||7|794,597|894,416|
|Unrestricted|funds|||||
|Income and expenditure<br>account|||8|10,853|10,176|
|||||805,450|904,592|





## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

|2) Investment<br>Income|2) Investment<br>Income|2) Investment<br>Income||||
|---|---|---|---|---|---|
|||||2023f|2022f|
|Dividends||||27,857|26,362|
|Interest||||163||
|3) Investment<br>Summary||||||
|||||2023f|2022<br>f|
|Market value 6 April||2022||860,423|838,662|
|Acquisitions||||43,373|82,603|
|Disposals at opening||market value||(59,87'I )|(100,902)|
|Net (losses)gains|on|revaluation||~79 847|40 060|
|Market value 5 April||2023||||
|Historical cost 5|April|2023||||
|4) Cash at Bank||||||
|||||2022|2022f|
|Current account||||11,019|9,819|
|Charles Stanley|deposit|||33698|37700|
|5) Creditors||||||
|||||2023f|2022<br>f|
|Accruals||||||
|6) Endowment|Funds|||||
|||||2023|2022|
|||||f|f|
|Capital<br>Fund||||||
|Balance brought|forward||6 April 2022|894,416|854,224|
|Gains on sales of investments||||(13,059)|17,376|
|Revaluation<br>of investments<br>Brokers fees||||(79,847)<br>~6913|140,060<br>~7244|
|Balance carried|forward||5 April 2023|||





|7) Unrestricted|Funds|||||||
|---|---|---|---|---|---|---|---|
|||||||2022|2022|
|||||||E|f|
|Income and expenditure||account||||||
|Balance brought|forward<br>6|April|2022|||10,176|17,653|
|Surplus/(Deficit)|for the year|||||677|~17477|
|Balance carried|forward<br>5 April 2023|||||||
|9)Analysis<br>of net assets||between||funds||||
||||||Endowment|Unrestricted|Total|
||||||Fundsf|Funds<br>E|E|
|Fund Balances|at 5 April|2023|are|||||
|represented<br>by||||||||
|Investments|||||764,078||764,078|
|Current assets|||||32,119|12,598|44,717|
|Current<br>liabilities|||||~1600|~1745|~3345|
|Total net assets||||||||
|Unrealised<br>gains included||above||||||
|On investments|||||148939||'I48 939|
|Total unrealised|gains at 5|April|2023|||||
|Reconciliation<br>of movements|||in|||||
|unrealised<br>gains on investments||||||||
|Unrealised<br>gains|at 6April|2022|||242,904||242,904|
|In respect ofdisposals|||||(14,118)||(14,118)|
|Losses on revaluations<br>in the year|||||~79 847||~79 847|
|Unrealised<br>gains|at 5 April|2023||||||





## 

##